Analyst Research: AbbVie Inc (ABBV.K)

ABBV.K on New York Consolidated

67.71USD
19 Dec 2014
Price Change (% chg)

$-0.21 (-0.31%)
Prev Close
$67.92
Open
$67.69
Day's High
$68.62
Day's Low
$66.84
Volume
12,631,038
Avg. Vol
11,871,860
52-wk High
$70.76
52-wk Low
$45.50

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - ABBVIE INC (ABBV-N) 5 Dec 2014 Thomson Reuters Stock Report 12 25.00
Wright Investors Service Comprehensive Report for Abbvie Inc 4 Dec 2014 Wright Reports 52 75.00
ValuEngine Industry Report for Large CAP Pharma 4 Dec 2014 ValuEngine, Inc. 10 49.00
Trading Report for (ABBV). A detailed report, including free correlated market analysis, and updates. 4 Dec 2014 Stock Traders Daily 6 20.00
ABBV: Due Diligence Review: Forensic Earnings and Valuation 4 Dec 2014 New Constructs, LLC 9 25.00
ValuEngine Rating and Forecast Report for ABBV 30 Nov 2014 ValuEngine, Inc. 11 25.00
AbbVie Inc 29 Nov 2014 S&P Capital IQ – STARS Reports 11 127.00
ABBVIE INC (ABBV) - REPORT FOR ACTIVE TRADERS 28 Nov 2014 Pechala's Reports 1 25.00
AbbVie Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 28 Nov 2014 Reuters Investment Profile 12 20.00
Value Graph: ABBVIE -- ABBV 27 Nov 2014 Ford Investor Services, Inc. 1 12.00
 
Name Age Since Current Position

Richard Gonzalez

60 2013 Chairman of the Board, Chief Executive Officer

William Chase

46 2013 Chief Financial Officer, Executive Vice President

Michael Severino

48 2014 Executive Vice President - Research & Development, Chief Scientific Officer

Laura Schumacher

50 2013 Executive Vice President - Business Development, External Affairs, General Counsel

Carlos Alban

51 2013 Executive Vice President - Commercial Operations
Search Stocks